Hanh Nho Nguyen

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Amgen Inc., Blinkbio, Inc.. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hanh Nho Nguyen. Retrieved from https://idiyas.com/inventor/hanh-nho-nguyen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 3)

% Patents Active = 86.4

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 6.9

ph-index = 7

Forward Citations = 243(Granted Patents)

Location History:

Arlington, MA (US) (2009 - 2016)
Jupiter, FL (US) (2016 - 2022)

Company Filing History:

Years Active: 2009-2022

Loading Chart...

Areas of Expertise:

Sodium Channel Inhibitors

Therapeutic Payloads

Drug Conjugates

Aurora Kinase Modulators

Beta-Secretase Modulators

Dihydrobenzoxazine

Carboxamides

Bicyclic Compounds

Heteroaryl Compounds

Spiro-Tetracyclic Compounds

Protein Kinase Modulators

Multi-Cyclic Compounds

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11497757 - Silanol based therapeutic payloads (2022-11-15),

2. 11291731 - Silicon based drug conjugates and methods of using same (2022-04-05),

3. 10716801 - Silanol based therapeutic payloads (2020-07-21),

4. 10293053 - Silanol based therapeutic payloads (2019-05-21),

5. 10064880 - Silanol based therapeutic payloads (2018-09-04),

6. 9931407 - Silicon based drug conjugates and methods of using same (2018-04-03),

7. 9776995 - Bicyclic sulfonamide compounds as sodium channel inhibitors (2017-10-03),

8. 9458152 - Bicyclic sulfonamide compounds as sodium channel inhibitors (2016-10-04),

9. 9346798 - Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors (2016-05-24),

10. 9334269 - Carboxamides as inhibitors of voltage-gated sodium channels (2016-05-10),

11. 9212182 - Bicyclic sulfonamide compounds as sodium channel inhibitors (2015-12-15),

12. 9126935 - Aurora kinase modulators and methods of use (2015-09-08),

13. 9079902 - Heteroaryl sodium channel inhibitors (2015-07-14),

14. 9012443 - Bicyclic aryl and heteroaryl sodium channel inhibitors (2015-04-21),

15. 8883782 - Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use (2014-11-11),

Title: The Innovative Contributions of Hanh Nho Nguyen

Introduction: Hanh Nho Nguyen is a prominent inventor based in Arlington, MA. He holds an impressive portfolio of 22 patents, reflecting his significant contributions to the field of therapeutics and drug delivery systems. His work demonstrates a commitment to advancing healthcare through innovative solutions.

Latest Patents: Nguyen's most recent patents include groundbreaking developments in therapeutic payloads and drug conjugates. One notable invention, titled "Silanol Based Therapeutic Payloads," describes silanol-based systems that encompass a silanol terminus, a divalent spacer moiety, and a drug moiety intended to effect beneficial changes on target cells or tissues. Another patent, "Silicon Based Drug Conjugates and Methods of Using Same," focuses on silicon-based conjugates capable of delivering multiple payload moieties to specific target locations within the body. This invention includes a silicon-heteroatom core and various additional components, allowing for improved targeting and efficacy of therapeutic and imaging agents.

Career Highlights: Hanh Nho Nguyen has had a substantial impact on the pharmaceutical industry through his roles in renowned companies, including Amgen Inc. and BlinkBio, Inc. His expertise and innovative mindset have helped shape various projects aimed at enhancing drug delivery mechanisms and therapeutic applications.

Collaborations: Throughout his career, Nguyen has collaborated with talented individuals, such as Karina Romero and Holly L Deak. These partnerships have fostered a dynamic exchange of ideas, enriching the innovative process and leading to the development of his influential patents.

Conclusion: Hanh Nho Nguyen continues to make significant strides in the field of innovation with his extensive patent portfolio and collaborative efforts. His work promises to drive advancements in therapeutic payloads and drug delivery systems, ultimately benefiting patient care and treatment outcomes.

Profile summary based on public USPTO records.